TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Hepatitis Drugs 1.2 Key Market Segments 1.2.1 Hepatitis Drugs Segment by Type 1.2.2 Hepatitis Drugs Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Hepatitis Drugs Market Overview 2.1 Global Market Overview 2.1.1 Global Hepatitis Drugs Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Hepatitis Drugs Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Hepatitis Drugs Market Competitive Landscape 3.1 Global Hepatitis Drugs Sales by Manufacturers (2017-2022) 3.2 Global Hepatitis Drugs Revenue Market Share by Manufacturers (2017-2022) 3.3 Hepatitis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Hepatitis Drugs Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Hepatitis Drugs Sales Sites, Area Served, Product Type 3.6 Hepatitis Drugs Market Competitive Situation and Trends 3.6.1 Hepatitis Drugs Market Concentration Rate 3.6.2 Global 5 and 10 Largest Hepatitis Drugs Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Hepatitis Drugs Industry Chain Analysis 4.1 Hepatitis Drugs Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Hepatitis Drugs Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Hepatitis Drugs Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Hepatitis Drugs Sales Market Share by Type (2017-2022) 6.3 Global Hepatitis Drugs Market Size Market Share by Type (2017-2022) 6.4 Global Hepatitis Drugs Price by Type (2017-2022) 7 Hepatitis Drugs Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Hepatitis Drugs Market Sales by Application (2017-2022) 7.3 Global Hepatitis Drugs Market Size (M USD) by Application (2017-2022) 7.4 Global Hepatitis Drugs Sales Growth Rate by Application (2017-2022) 8 Hepatitis Drugs Market Segmentation by Region 8.1 Global Hepatitis Drugs Sales by Region 8.1.1 Global Hepatitis Drugs Sales by Region 8.1.2 Global Hepatitis Drugs Sales Market Share by Region 8.2 North America 8.2.1 North America Hepatitis Drugs Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Hepatitis Drugs Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Hepatitis Drugs Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Hepatitis Drugs Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Hepatitis Drugs Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 F. Hoffmann-La Roche 9.1.1 F. Hoffmann-La Roche Hepatitis Drugs Basic Information 9.1.2 F. Hoffmann-La Roche Hepatitis Drugs Product Overview 9.1.3 F. Hoffmann-La Roche Hepatitis Drugs Product Market Performance 9.1.4 F. Hoffmann-La Roche Business Overview 9.1.5 F. Hoffmann-La Roche Hepatitis Drugs SWOT Analysis 9.1.6 F. Hoffmann-La Roche Recent Developments 9.2 Gilead Sciences 9.2.1 Gilead Sciences Hepatitis Drugs Basic Information 9.2.2 Gilead Sciences Hepatitis Drugs Product Overview 9.2.3 Gilead Sciences Hepatitis Drugs Product Market Performance 9.2.4 Gilead Sciences Business Overview 9.2.5 Gilead Sciences Hepatitis Drugs SWOT Analysis 9.2.6 Gilead Sciences Recent Developments 9.3 GlaxoSmithKline 9.3.1 GlaxoSmithKline Hepatitis Drugs Basic Information 9.3.2 GlaxoSmithKline Hepatitis Drugs Product Overview 9.3.3 GlaxoSmithKline Hepatitis Drugs Product Market Performance 9.3.4 GlaxoSmithKline Business Overview 9.3.5 GlaxoSmithKline Hepatitis Drugs SWOT Analysis 9.3.6 GlaxoSmithKline Recent Developments 9.4 Johnson and Johnson 9.4.1 Johnson and Johnson Hepatitis Drugs Basic Information 9.4.2 Johnson and Johnson Hepatitis Drugs Product Overview 9.4.3 Johnson and Johnson Hepatitis Drugs Product Market Performance 9.4.4 Johnson and Johnson Business Overview 9.4.5 Johnson and Johnson Hepatitis Drugs SWOT Analysis 9.4.6 Johnson and Johnson Recent Developments 9.5 Merck 9.5.1 Merck Hepatitis Drugs Basic Information 9.5.2 Merck Hepatitis Drugs Product Overview 9.5.3 Merck Hepatitis Drugs Product Market Performance 9.5.4 Merck Business Overview 9.5.5 Merck Hepatitis Drugs SWOT Analysis 9.5.6 Merck Recent Developments 9.6 Novartis 9.6.1 Novartis Hepatitis Drugs Basic Information 9.6.2 Novartis Hepatitis Drugs Product Overview 9.6.3 Novartis Hepatitis Drugs Product Market Performance 9.6.4 Novartis Business Overview 9.6.5 Novartis Recent Developments 9.7 Vertex Pharmaceuticals 9.7.1 Vertex Pharmaceuticals Hepatitis Drugs Basic Information 9.7.2 Vertex Pharmaceuticals Hepatitis Drugs Product Overview 9.7.3 Vertex Pharmaceuticals Hepatitis Drugs Product Market Performance 9.7.4 Vertex Pharmaceuticals Business Overview 9.7.5 Vertex Pharmaceuticals Recent Developments 9.8 Abbvie 9.8.1 Abbvie Hepatitis Drugs Basic Information 9.8.2 Abbvie Hepatitis Drugs Product Overview 9.8.3 Abbvie Hepatitis Drugs Product Market Performance 9.8.4 Abbvie Business Overview 9.8.5 Abbvie Recent Developments 9.9 Achillion Pharmaceuticals 9.9.1 Achillion Pharmaceuticals Hepatitis Drugs Basic Information 9.9.2 Achillion Pharmaceuticals Hepatitis Drugs Product Overview 9.9.3 Achillion Pharmaceuticals Hepatitis Drugs Product Market Performance 9.9.4 Achillion Pharmaceuticals Business Overview 9.9.5 Achillion Pharmaceuticals Recent Developments 9.10 Bristol-Myers Squibb 9.10.1 Bristol-Myers Squibb Hepatitis Drugs Basic Information 9.10.2 Bristol-Myers Squibb Hepatitis Drugs Product Overview 9.10.3 Bristol-Myers Squibb Hepatitis Drugs Product Market Performance 9.10.4 Bristol-Myers Squibb Business Overview 9.10.5 Bristol-Myers Squibb Recent Developments 10 Hepatitis Drugs Market Forecast by Region 10.1 Global Hepatitis Drugs Market Size Forecast 10.2 Global Hepatitis Drugs Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Hepatitis Drugs Market Size Forecast by Country 10.2.3 Asia Pacific Hepatitis Drugs Market Size Forecast by Region 10.2.4 South America Hepatitis Drugs Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Hepatitis Drugs by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Hepatitis Drugs Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Hepatitis Drugs by Type (2022-2028) 11.1.2 Global Hepatitis Drugs Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Hepatitis Drugs by Type (2022-2028) 11.2 Global Hepatitis Drugs Market Forecast by Application (2022-2028) 11.2.1 Global Hepatitis Drugs Sales (K Units) Forecast by Application 11.2.2 Global Hepatitis Drugs Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Hepatitis Drugs Market Size (M USD) Comparison by Region (M USD) Table 5. Global Hepatitis Drugs Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Hepatitis Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Hepatitis Drugs Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Hepatitis Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Drugs as of 2021) Table 10. Global Market Hepatitis Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Hepatitis Drugs Sales Sites and Area Served Table 12. Manufacturers Hepatitis Drugs Product Type Table 13. Global Hepatitis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Hepatitis Drugs Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Hepatitis Drugs Market Challenges Table 22. Market Restraints Table 23. Global Hepatitis Drugs Sales by Type (K Units) Table 24. Global Hepatitis Drugs Market Size by Type (M USD) Table 25. Global Hepatitis Drugs Sales (K Units) by Type (2017-2022) Table 26. Global Hepatitis Drugs Sales Market Share by Type (2017-2022) Table 27. Global Hepatitis Drugs Market Size (M USD) by Type (2017-2022) Table 28. Global Hepatitis Drugs Market Size Share by Type (2017-2022) Table 29. Global Hepatitis Drugs Price (USD/Unit) by Type (2017-2022) Table 30. Global Hepatitis Drugs Sales (K Units) by Application Table 31. Global Hepatitis Drugs Market Size by Application Table 32. Global Hepatitis Drugs Sales by Application (2017-2022) & (K Units) Table 33. Global Hepatitis Drugs Sales Market Share by Application (2017-2022) Table 34. Global Hepatitis Drugs Sales by Application (2017-2022) & (M USD) Table 35. Global Hepatitis Drugs Market Share by Application (2017-2022) Table 36. Global Hepatitis Drugs Sales Growth Rate by Application (2017-2022) Table 37. Global Hepatitis Drugs Sales by Region (2017-2022) & (K Units) Table 38. Global Hepatitis Drugs Sales Market Share by Region (2017-2022) Table 39. North America Hepatitis Drugs Sales by Country (2017-2022) & (K Units) Table 40. Europe Hepatitis Drugs Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Hepatitis Drugs Sales by Region (2017-2022) & (K Units) Table 42. South America Hepatitis Drugs Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Hepatitis Drugs Sales by Region (2017-2022) & (K Units) Table 44. F. Hoffmann-La Roche Hepatitis Drugs Basic Information Table 45. F. Hoffmann-La Roche Hepatitis Drugs Product Overview Table 46. F. Hoffmann-La Roche Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. F. Hoffmann-La Roche Business Overview Table 48. F. Hoffmann-La Roche Hepatitis Drugs SWOT Analysis Table 49. F. Hoffmann-La Roche Recent Developments Table 50. Gilead Sciences Hepatitis Drugs Basic Information Table 51. Gilead Sciences Hepatitis Drugs Product Overview Table 52. Gilead Sciences Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Gilead Sciences Business Overview Table 54. Gilead Sciences Hepatitis Drugs SWOT Analysis Table 55. Gilead Sciences Recent Developments Table 56. GlaxoSmithKline Hepatitis Drugs Basic Information Table 57. GlaxoSmithKline Hepatitis Drugs Product Overview Table 58. GlaxoSmithKline Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. GlaxoSmithKline Business Overview Table 60. GlaxoSmithKline Hepatitis Drugs SWOT Analysis Table 61. GlaxoSmithKline Recent Developments Table 62. Johnson and Johnson Hepatitis Drugs Basic Information Table 63. Johnson and Johnson Hepatitis Drugs Product Overview Table 64. Johnson and Johnson Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Johnson and Johnson Business Overview Table 66. Johnson and Johnson Hepatitis Drugs SWOT Analysis Table 67. Johnson and Johnson Recent Developments Table 68. Merck Hepatitis Drugs Basic Information Table 69. Merck Hepatitis Drugs Product Overview Table 70. Merck Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. Merck Business Overview Table 72. Merck Hepatitis Drugs SWOT Analysis Table 73. Merck Recent Developments Table 74. Novartis Hepatitis Drugs Basic Information Table 75. Novartis Hepatitis Drugs Product Overview Table 76. Novartis Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Novartis Business Overview Table 78. Novartis Recent Developments Table 79. Vertex Pharmaceuticals Hepatitis Drugs Basic Information Table 80. Vertex Pharmaceuticals Hepatitis Drugs Product Overview Table 81. Vertex Pharmaceuticals Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Vertex Pharmaceuticals Business Overview Table 83. Vertex Pharmaceuticals Recent Developments Table 84. Abbvie Hepatitis Drugs Basic Information Table 85. Abbvie Hepatitis Drugs Product Overview Table 86. Abbvie Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Abbvie Business Overview Table 88. Abbvie Recent Developments Table 89. Achillion Pharmaceuticals Hepatitis Drugs Basic Information Table 90. Achillion Pharmaceuticals Hepatitis Drugs Product Overview Table 91. Achillion Pharmaceuticals Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Achillion Pharmaceuticals Business Overview Table 93. Achillion Pharmaceuticals Recent Developments Table 94. Bristol-Myers Squibb Hepatitis Drugs Basic Information Table 95. Bristol-Myers Squibb Hepatitis Drugs Product Overview Table 96. Bristol-Myers Squibb Hepatitis Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Bristol-Myers Squibb Business Overview Table 98. Bristol-Myers Squibb Recent Developments Table 99. Global Hepatitis Drugs Sales Forecast by Region (K Units) Table 100. Global Hepatitis Drugs Market Size Forecast by Region (M USD) Table 101. North America Hepatitis Drugs Sales Forecast by Country (2022-2028) & (K Units) Table 102. North America Hepatitis Drugs Market Size Forecast by Country (2022-2028) & (M USD) Table 103. Europe Hepatitis Drugs Sales Forecast by Country (2022-2028) & (K Units) Table 104. Europe Hepatitis Drugs Market Size Forecast by Country (2022-2028) & (M USD) Table 105. Asia Pacific Hepatitis Drugs Sales Forecast by Region (2022-2028) & (K Units) Table 106. Asia Pacific Hepatitis Drugs Market Size Forecast by Region (2022-2028) & (M USD) Table 107. South America Hepatitis Drugs Sales Forecast by Country (2022-2028) & (K Units) Table 108. South America Hepatitis Drugs Market Size Forecast by Country (2022-2028) & (M USD) Table 109. Middle East and Africa Hepatitis Drugs Consumption Forecast by Country (2022-2028) & (Units) Table 110. Middle East and Africa Hepatitis Drugs Market Size Forecast by Country (2022-2028) & (M USD) Table 111. Global Hepatitis Drugs Sales Forecast by Type (2022-2028) & (K Units) Table 112. Global Hepatitis Drugs Market Size Forecast by Type (2022-2028) & (M USD) Table 113. Global Hepatitis Drugs Price Forecast by Type (2022-2028) & (USD/Unit) Table 114. Global Hepatitis Drugs Sales (K Units) Forecast by Application (2022-2028) Table 115. Global Hepatitis Drugs Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Hepatitis Drugs Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Hepatitis Drugs Market Size (M USD), 2017-2028 Figure 5. Global Hepatitis Drugs Market Size (M USD) (2017-2028) Figure 6. Global Hepatitis Drugs Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Hepatitis Drugs Market Size (M USD) by Country (M USD) Figure 11. Hepatitis Drugs Sales Share by Manufacturers in 2020 Figure 12. Global Hepatitis Drugs Revenue Share by Manufacturers in 2020 Figure 13. Hepatitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Hepatitis Drugs Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Hepatitis Drugs Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Hepatitis Drugs Market Share by Type Figure 18. Sales Market Share of Hepatitis Drugs by Type (2017-2022) Figure 19. Sales Market Share of Hepatitis Drugs by Type in 2021 Figure 20. Market Size Share of Hepatitis Drugs by Type (2017-2022) Figure 21. Market Size Market Share of Hepatitis Drugs by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Hepatitis Drugs Market Share by Application Figure 24. Global Hepatitis Drugs Sales Market Share by Application (2017-2022) Figure 25. Global Hepatitis Drugs Sales Market Share by Application in 2021 Figure 26. Global Hepatitis Drugs Market Share by Application (2017-2022) Figure 27. Global Hepatitis Drugs Market Share by Application in 2020 Figure 28. Global Hepatitis Drugs Sales Growth Rate by Application (2017-2022) Figure 29. Global Hepatitis Drugs Sales Market Share by Region (2017-2022) Figure 30. North America Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Hepatitis Drugs Sales Market Share by Country in 2020 Figure 32. U.S. Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Hepatitis Drugs Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Hepatitis Drugs Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Hepatitis Drugs Sales Market Share by Country in 2020 Figure 37. Germany Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Hepatitis Drugs Sales and Growth Rate (K Units) Figure 43. Asia Pacific Hepatitis Drugs Sales Market Share by Region in 2020 Figure 44. China Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Hepatitis Drugs Sales and Growth Rate (K Units) Figure 50. South America Hepatitis Drugs Sales Market Share by Country in 2020 Figure 51. Brazil Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Hepatitis Drugs Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Hepatitis Drugs Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Hepatitis Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Hepatitis Drugs Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Hepatitis Drugs Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Hepatitis Drugs Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Hepatitis Drugs Market Share Forecast by Type (2022-2028) Figure 65. Global Hepatitis Drugs Sales Forecast by Application (2022-2028) Figure 66. Global Hepatitis Drugs Market Share Forecast by Application (2022-2028)

•F. Hoffmann-La Roche •Gilead Sciences •GlaxoSmithKline •Johnson and Johnson •Merck •Novartis •Vertex Pharmaceuticals •Abbvie •Achillion Pharmaceuticals •Bristol-Myers Squibb